LGL leukemia and HTLV

AIDS Research and Human Retroviruses

Volumn 26, Issue 1, 2010, Pages 33-40

  Thomas, Anish ^a   Perzova, Raisa ^a   Abbott, Lynn ^a   Benz, Patricia ^a   Poiesz, Michael J ^b   Dube, Syamalima ^a   Loughran, Thomas ^c   Ferrer, Jorge ^d   Sheremata, William ^e   Glaser, Jordan ^f   Leon Ponte, Matilde ^g   Poiesz, Bernard J ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c PENN STATE CANCER INSTITUTE   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^f STATEN ISLAND UNIVERSITY HOSPITAL   (United States)

^g ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; GAG PROTEIN; GP 21; HUMAN ENDOGENOUS RETROVIRUS K10 PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; BLOOD DONOR; CONTROLLED STUDY; CROSS REACTION; ENZYME IMMUNOASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; HUMAN T CELL LEUKEMIA VIRUS 4; LARGE GRANULAR LYMPHOCYTE LEUKEMIA; MAJOR CLINICAL STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SERUM; SPINAL CORD DISEASE; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIBODIES, VIRAL; BLOTTING, WESTERN; CROSS REACTIONS; ENDOGENOUS RETROVIRUSES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HIV-2; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2; HUMAN T-LYMPHOTROPIC VIRUS 3; HUMANS; LEUKEMIA VIRUS, BOVINE; LEUKEMIA, LARGE GRANULAR LYMPHOCYTIC; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

EID: 76449089279     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2009.0124     Document Type: Article

References (56)

1. Poiesz BJ, Poiesz MJ, and Choi D: The human T-cell lymphoma/leukemia viruses. Cancer Invest 2003;21:253-277.
2. Wolfe ND, Heneine W, Carr JK, Garcia AD, Shanmugam V, Tamoufe U, Torimiro JN, Prosser AT, Lebreton M, Mpoudi- Ngole E, McCutchan FE, Birx DL, et al.: Emergence of unique primate T-lymphotropic viruses among central african bushmeat hunters. Proc Natl Acad Sci USA 2005;102:7994-7999.
3. Van Dooren S, Meertens L, Lemey P, Gessain A, and Vandamme AM: Full-genome analysis of a highly divergent simian T-cell lymphotropic virus type 1 strain in Macaca arctoides. J Gen Virol 2005;86:1953-1959.
4. Salemi M, Desmyter J, and Vandamme A: Tempo and mode of human and simian T-lymphotropic virus (HTLV/STLV) evolution revealed by analyses of full-genome sequences. Mol Biol Evol 2000;17:374-386.
5. Slattery JP, Franchini G, and Gessain A: Genomic evolution, patterns of global dissemination, and interspecies transmission of human and simian T-cell leukemia/lymphotropic viruses. Genome Res 1999;9:525-540.
6. Calattini S, Chevalier SA, Duprez R, Afonso P, Froment A, Gessain A, and Mahieux R: Human T-cell lymphotropic virus type 3: Complete nucleotide sequence and characterization of the human tax3 protein. J Virol 2006;80:9876-9888.
7. Calattini S, Chevalier SA, Duprez R, Bassot S, Froment A, Mahieux R, and Gessain A: Discovery of a new human T-cell lymphotropic virus (HTLV-3) in central Africa. Retrovirology 2005;2:30.
8. Gessain A, Mahieux R, and de The G: Genetic variability and molecular epidemiology of human and simian T cell leukemia/lymphoma virus type I. J Acquir Immune Defic Syndr Hum Retrovirol 1996;13:S132-145.
9. Switzer WM, Salemi M, Qari SH, Jia H, Gray RR, Katzourakis A, Marriott SJ, Pryor KN, Wolfe ND, Burke DS, Folke TM, and Heneine W: Ancient, independent evolution and distinct molecular features of the novel human T-lymphotropic virus type 4. Retrovirology 2009;6:90.
10. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, and Gallo RC: Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980;77:7415-7419.
11. Hinuma Y, Komoda H, Chosa T, Kondo T, Kohakura M, Takenaka T, Kikuchi M, Ichimaru M, Yunoki K, Sato I, Matsuo R, Takiuchi Y, et al.: Antibodies to adult T-cell leukemia-virus-associated antigen (ATLA) in sera from patients with ATL and controls in Japan: A nation-wide sero-epidemiologic study. Int J Cancer 1982;29:31-35.
12. Kalyanaraman V, Sarngadharan M, Robert-Guroff M, Miyoshi I, Golde D, and Gallo R: A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Science 1982;218:4571-4573.
13. Rosenblatt JD, Golde DW, Wachsman W, Giorgi JV, Jacobs A, Schmidt GM, Quan S, Gasson JC, and Chen IS: A second isolate of HTLV-II associated with atypical hairy-cell leukemia. N Engl J Med 1986;315:72-77.
14. Loughran TP, Jr, Coyle T, Sherman MP, Starkebaum G, Ehrlich GD, Ruscetti FW, and Poiesz BJ: Detection of human T-cell leukemia/lymphoma virus, type II, in a patient with large granular lymphocyte leukemia. Blood 1992;80:1116-1119.
15. Loughran TP, Jr, Hadlock KG, Perzova R, Gentile TC, Yang Q, Foung SK, and Poiesz BJ: Epitope mapping of HTLV envelope seroreactivity in LGL leukaemia. Br J Haematol 1998;101:318-324.
16. Martin MP, Biggar RJ, Hamlin-Green G, Staal S, and Mann D: Large granular lymphocytosis in a patient infected with HTLV-II. AIDS Res Human Retroviruses 1999;9:715-719.
17. Sohn CC, Blayney DW, Misset JL, Mathe G, Flandrin G, Moran EM, Jensen FC, Winberg CD, and Rappaport H: Leukopenic chronic T cell leukemia mimicking hairy cell leukemia: Association with human retroviruses. Blood 1986; 67:949-956.
18. Poiesz B, Dube D, Dube S, Love J, Papsidero L, Uner A, and Hutchinson R: HTLV-II associated cutaneous T-cell lymphoma in a patient with HIV-1 infection. N Engl J Med 2000;342:930-936.
19. Jacobson S, Lehky T, Nishimura M, Robinson S, McFarlin DE, and Dhib-Jalbut S: Isolation of HTLV-II from a patient with chronic, progressive neurological disease clinically indistinguishable from HTLV-I-associated myelopathy/tropical spastic paraparesis. Ann Neurol 1993;33:392-396.
20. Murphy EL, Fridey J, Smith JW, Engstrom J, Sacher RA, Miller K, Gibble J, Stevens J, Thomson R, Hansma D, Kaplan J, Khabbaz R, et al.: HTLV-associated myelopathy in a cohort of HTLV-I and HTLV-II-infected blood donors. The REDS investigators. Neurology 1997;48:315-320.
21. Loughran TP, Jr, Kadin ME, Starkebaum G, Abkowitz JL, Clark EA, Disteche C, Lum LG, and Slichter SJ: Leukemia of large granular lymphocytes: Association with clonal chromosomal abnormalities and autoimmune neutropenia, thrombocytopenia, and hemolytic anemia. Ann Int Med 1985;102:169-175.
22. Harper ME, Kaplan MH, Marselle LM, Pahwa SG, Chayt KJ, SarngadharanMG,Wong-Staal F, and Gallo RC: Concomitant infection with HTLV-I and HTLV-III in a patient with T8 lymphoproliferative disease. N Engl J Med 1986;315:1073-1078.
23. Pandolfi F, Shriver K, Scarselli E, Fiorelli V, Semenzato G, Zambello R, Chisesi T, de Rossi G, and Strong DM: HTLV-I antibodies and lymphoproliferative disease of granular lymphocytes. Lancet 1987;2:1527.
24. Starkebaum G, Loughran TP, Jr, Kalyanaraman VS, Kadin ME, Kidd PG, Singer JW, and Ruscetti FW: Serum reactivity to human T-cell leukaemia/lymphoma virus type I proteins in patients with large granular lymphocytic leukaemia. Lancet 1987;1:596-599.
25. Imamura N, Kuramoto A, Kawa-Ha K, Fujii H, and Takiguchi T: Negative association between the human T-cell leukaemia virus type I and large granular lymphocyte leukaemia in Japan. Lancet 1988;2:962.
26. Levitt LJ, Reyes GR, Moonka DK, Bensch K, Miller RA, and Engleman EG: Human T cell leukemia virus-I-associated T-suppressor cell inhibition of erythropoiesis in a patient with pure red cell aplasia and chronic T gamma-lymphoproliferative disease. J Clin Invest 1988;81:538-548.
27. Dezzutti CS, Rudolph DL, Roberts CR, and Lal RB: Characterization of human T-lymphotropic virus type I- and IIinfected T-cell lines: Antigenic, phenotypic, and genotypic analysis. Virus Res 1993;29:59-70.
28. Loughran TP, Jr, Sherman MP, Ruscetti FW, Frey S, Coyle T, Montagna RA, Jones B, Starkebaum G, and Poiesz BJ: Prototypical HTLV-I/II infection is rare in LGL leukemia. Leuk Res 1994;18:423-429.
29. Heneine W, Chan WC, Lust JA, Sinha SD, Zaki SR, Khabbaz RF, and Kaplan JE: HTLV-II infection is rare in patients with large granular lymphocyte leukemia. J Acquir Immune Defic Syndr 1994;7:736-737.
30. Fouchard N, Flageul B, Bagot M, Avril MF, Hermine O, Sigaux F, Merle-Beral H, Troussard X, Delfraissy JF, and De The G: Lack of evidence of HTLV-I/II infection in T CD8 malignant or reactive lymphoproliferative disorders in France: A serological and/or molecular study of 169 cases. Leukemia 1995;9:2087-2092.
31. Pombo De Oliveira MS, Matutes E, Schulz T, Carvalho SM, Noronha H, Reaves JD, Loureiro P, Machado C, and Catovsky D: T-cell malignancies in Brazil clinicopathological and molecular studies of HTLV-I-positive and -negative cases. Int J Cancer 1995;60:823-827.
32. Rose MG and Berliner N: T-cell large granular lymphocyte leukemia and related disorders. Oncologist 2004;9:247-258.
33. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, and Nagata S: Lymphoproliferation disorder in mice explained by defects in fas antigen that mediates apoptosis. Nature 1992;356:314-317.
34. Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, Suda T, and Nagata S: Generalized lymphoproliferative disease in mice, caused by a point mutation in the fas ligand. Cell 1994;76:969-976.
35. Lamy T and Loughran TP: Current concepts: Large granular lymphocyte leukemia. Blood Rev 1999;13:230-240.
36. Pawson R, Schulz TF, Matutes E, and Catovsky D: The human T-cell lymphotropic viruses, types I/II are not involved in T prolymphocytic leukemia and large granular lymphocytic leukemia. Leukemia 1997;11:1305-1311.
37. Perzova RN, Loughran TP, Jr, Dube S, Ferrer J, Esteban E, and Poiesz BJ: Lack of BLV and PTLV DNA sequences in the majority of patients with large granular lymphocyte leukemia. Br J Hematol 2000;109:64-70.
38. Sokol L, Agrawal D, and Loughran TP, Jr: Characterzation of HTLV envelope seroreactivity in large granular lymphocyte leukemia. Leukemia Res 2004;29:381-387.
39. Marchler-Bauer A, Anderson JB, Derbyshire MK, DeWeese- Scot C, Gonzales Nr, Gwadz M, Luning H, Sigian H, Hurwitz DI, Jackson JD, Ke Z, Krylov D, Lanczychi CJ, Liebert CA, Liu C, Lu S. Marchler GH, Mullokandov M, Song JS, Thanki N, Yamashita RA, Yin JJ, Zhang D, and Bryant SH: CDD: A conserved domain database for interactive domain family analysis. Nucl Acids Res 2006;35:237-240.
40. Tatusova TA and Madden TL: BLAST 2 Sequences, a new tool for comparing protein and nucleotide sequences. FEMS Microbiol Lett 1999;174:247-250.
41. Schä ffer AA, Aravind L, Madden TL, Shavirin S, Spouge JL, Wolf YI, Koonin EV, and Altschul SF: Improving the accuracy of PSI-BLAST protein database searches with composition-based statistics and other refinements. Nucleic Acids Res 2001;29:2994-3005.
42. Sokol L and Loughran TP Jr: Large granular lymphocyte leukemia. Oncologist 2006;11:263-273.
43. Anderson DW, Epstein JS, Pierick LT, Lee TH, Lairmore MD, Saxinger C, Kalyanaraman VS, Slamon D, Parks W, Poiesz BJ, and Blattner W: Development of the Public Health Service of criteria for serological confirmation of HTLV -I/II infections. In: Human Retrovirology (Blattner W, ed.), pp. 391-396. New York: Raven Press, 1990.
44. Ehrlich GD, Glaser JB, LaVigne K, Quan D, Mildvan D, Sninsky JJ, Kwok S, Papsidero L, and Poiesz BJ: Prevalence of human T-cell leukemia/lymphoma virus (HTLV) type II infection among high-risk individuals: Type-specific identification of HTLVs by polymerase chain reaction. Blood 1989;74:1658-1664.
45. Ehrlick GD, Davey FR, Kirshner JJ, Snmsky JJ, Kwok S, Wlamon DJ, Kalish R, and Poiesz BJ: A polyclonal CD4+ and CD8+ lymphocytosis in a patient doubly infected with HTLV-I and HIV-1: A clinical and molecular analysis. Am J Hematol 1989;30:128-139.
46. Goubau P, Brussel M, Vandamme A, Liu H, and Desmyter J: A primate T-lymphotropic virus, PTLV-L, different from human T-lymphotropic viruses types I and II, in a wildcaught baboon (Papio hamadryas). Proc Natl Acad Sci USA 1994;91:2848-2852.
47. Switzer W, Qari S, Wolfe N, Burke D, Folks T, and Heneine W: Ancient origin and molecular features of the novel human T-lymphotropic virus type 3 revealed by complete genome analysis. J Virol 2006;80:7427-7438.
48. Chevalier SA, Meertens L, Pise-Masison C, Calattini S, Park H, Alhaj AA, Zhou M, Gessain A, Kashanchi F, Brady JN, and Mahieux R: The tax protein from the primate T-cell lymphotropic virus type 3 is expressed in vivo and is functionally related to HTLV-1 Tax rather than HTLV-2 Tax. Oncogene 2006;4470-4482.
49. Duong YT, Jia H, Lust JA, Garica AD, Tiffany AJ, Heneine W, and Switzer W: Absence of evidence of HTLV-3 and HTLV-4 in patients with large granular lymphocyte (LGL) leukemia. AIDS Res Hum Retroviruses 2008;24:1503-1505.
50. Burmeister T, Schwartz S, Hummel M, Hoelzer D, and Thiel E: No genetic evidence for involvement of deltaretroviruses in adult patients with precursor and mature T-cell neoplasms. Retrovirology 2007;4:11.
51. Poiesz BJ, Papsidero LD, Ehrlich G, Sherman M, Dube S, Poiesz M, Dillon K, Ruscetti FW, Slamon D, Fang C, Williams A, Duggan D, Glaser J, Gottlieb A, Goldberg J, Ratner L, Phillips P, Han T, Friedman-Kien A, Siegal F, Rai K, Sawitsky A, Sheremata LW, Dosik H, Cunningham C, and Montagna R: Prevalence of HTLV-I-associated T-cell lymphoma. Am J Hematol 2001;66:32-38.
52. Perl A, Rosenblatt J, Chen I Sy, Di Vincenzo JP, Bever R, Poiesz BJ, and Abraham GN: Detection and cloning of new HTLV-related endogenous sequences in man. Nucleic Acids Res 1989;17:6841-6854.
53. Perl A, Colombo E, Dai H, Agarwal R, Banki K, Poiesz, BJ, Phillips PE, Hoch SO, Reveille JD, and Amett FC: Antibody reactivity to the HRES-1 endogenous retroviral element identifies a subset of patients with systemic lupus erythematosus and overlap syndromes. Correlation with antinuclear antibodies and HLA class II alleles. Arthritis Rheum 1995;38:1660-1671.
54. Ono M, Yasunaga T, Miyata T, and Ushikubo H: Nucleotide sequence of human endogenous retrovirus genome related to the mouse mammary tumor virus genome. J Virol 1986; 60:589-598.
55. Herve CA, Lugli EB, Brand A, Griffiths DJ, and Venables PJ: Autoantibodies to human endogenous retrovirus-K are frequently detected in health and disease and react with multiple epitopes. Clin Exp Immunol 2002;128:75-82.
56. Ejtehadi HD, Freimanis GL, Ali HA, Bowman S, Alavi A, Axford J, Callaghan R, and Nelson PN: The potential role of human endogenous retrovirus K10 in the pathogenesis of rheumatoid arthritis: A preliminary study. Ann Rheum Dis 2006;65:612-616.